Priority Date: 31.05.12 (US 201261653962P)

IN VITRO EMBRYO BLASTOCYST PREDICTION METHODS

  • Application ID: EP13796744
  • Status: EXAMINATION IN PROGRESS

Attorneys

no operation time available
1 office
active in Legal Services
operating since 1981
982.84
Headquarter in London and 8 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 174 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 31.05.2012 - Priority Date (US 201261653962P)
  • 05.12.2013 - Publication A2 (WO2013181549)
  • 08.04.2015 - Publication A2 (EP2855694)

IPC Classification